As several studies recently revealed mechanical regulations of receptor tyrosine kinase (RTK), including EGFR signaling in cancers [6,7,45,46], these together imply roles of EGFR dynamics in advanced malignancy in prostate cancer and their potential as biophysical markers for this disease. This evidence concerns the gene EGFR and prostate carcinoma.